Company / Operating Income
Exelixis Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$872.2M
FY2025
5-year range
$110.1M / $872.2M
FY2021-FY2025
Trend
+44.3%
vs FY2024
Sector context
#12 of 204
Health Care
What the data says
Among 204 Health Care companies, Exelixis is in the top 6% for operating income. Operating Income has increased for 3 consecutive years, from $110M in FY2022 to $872M in FY2025.
Based on SEC 10-K filings.
$872M in FY2025 with a 5-year CAGR of +51.3%. Top quartile in the Health Care sector.
Improved from $171M to $872M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- +99.4%
- 5-Year CAGR
- +51.3%
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 204This company $872.2M Sector average $107.8M
▼
+709.4% above sector average
Key checks
Key Insights
- Exelixis's operating income has grown for 3 consecutive years.
- 5-year CAGR of +51.3%, indicating consistent growth.
- In FY2025, operating income increased 44.3% year-over-year.
- Ranks #12 out of 204 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.33 (safe zone, above 2.9 threshold)
- Strong profit margin: 29.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 31.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $872.2M | +44.3% |
| FY2024 | $604.6M | +253.8% |
| FY2023 | $170.9M | +55.3% |
| FY2022 | $110.1M | -70.2% |
| FY2021 | $369.5M | +235.7% |
| FY2020 | $110.1M | -70.2% |
| FY2019 | $369.5M | +1413.7% |
| FY2018 | -$28.1M | -117.0% |
| FY2017 | $165.9M | +689.9% |
| FY2016 | -$28.1M | +76.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026